The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Adjuvant Treatment of Colorectal Cancer
Open accessAbstract
Colorectal cancer is the fourth most common noncutaneous malignancy in the United States and the second most frequent cause of cancer-related death. Approximately three quarters of patients are diagnosed with disease limited to the bowel wall or surrounding lymph nodes. Over the past decade, significant progress has been made in the treatment of localized colorectal cancer due to advances in surgery, radiotherapy, and chemotherapy. For patients with Stage III colon cancer, an overall survival benefit for fluorouracil-based chemotherapy has been firmly established, and recent data have shown further efficacy through the inclusion of oxaliplatin into adjuvant treatment programs. For patients with Stage II colon cancer, the use of adjuvant chemotherapy remains controversial, but may be appropriate in a subset of individuals at high risk for disease recurrence. In the treatment of patients with rectal cancer, improved outcomes have been noted with the use of total mesorectal excision and preoperative concurrent chemoradiotherapy. Current randomized clinical trials in the adjuvant therapy of colorectal cancer are examining the value of adding agents known to be active in metastatic disease, including those that modify specific molecular targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
Sauer, R., Becker, H., Hohenberger, W., Rödel, C., Wittekind, C., Fietkau, R., Martus, P., Tschmelitsch, J., Hager, E., Hess, C. F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040694 · Cited by 6,050
Cunningham, D., Humblet, Y., Siena, S., Khayat, D., Bleiberg, H., Santoro, A., Bets, D., Mueser, M., Harstrick, A., Verslype, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033025 · Cited by 5,035
Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer
Kapiteijn, E., Marijnen, C. A. M., Nagtegaal, I. D., Putter, H., Steup, W. H., Wiggers, T., Rutten, H. J. T., Pahlman, L., Glimelius, B., van Krieken, J. H. J. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010580 · Cited by 4,205
de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., Boni, C., Cortes-Funes, H., Cervantes, A., Freyer, G., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.2938 · Cited by 3,815
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
André, T., Boni, C., Mounedji-Boudiaf, L., Navarro, M., Tabernero, J., Hickish, T., Topham, C., Zaninelli, M., Clingan, P., Bridgewater, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032709 · Cited by 3,689
Douillard, J., Cunningham, D., Roth, A., Navarro, M., James, R., Karasek, P., Jandik, P., Iveson, T., Carmichael, J., Alakl, M., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02034-1 · Cited by 3,256
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
Saltz, L. B., Cox, J. V., Blanke, C., Rosen, L. S., Fehrenbacher, L., Moore, M. J., Maroun, J. A., Ackland, S. P., Locker, P. K., Pirotta, N., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431302 · Cited by 3,005
Tournigand, C., André, T., Achille, E., Lledo, G., Flesh, M., Mery-Mignard, D., Quinaux, E., Couteau, C., Buyse, M., Ganem, G., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.113 · Cited by 2,915
Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer
(1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361402 · Cited by 2,517
AJCC Cancer Staging Manual. 6th ed
Greene, F., Page, D., Id, F., Fritz, J., Balch, C., & Haller, D. (2002) · Cited by 2,324
Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., Laurie, J. A., Goodman, P. J., Ungerleider, J. S., Emerson, W. A., Tormey, D. C., Glick, J. H., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002083220602 · Cited by 2,256
Goldberg, R. M., Sargent, D. J., Morton, R. F., Fuchs, C. S., Ramanathan, R. K., Williamson, S. K., Findlay, B. P., Pitot, H. C., & Alberts, S. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.046 · Cited by 2,249
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
Hutchins, L. F., Unger, J. M., Crowley, J. J., Coltman, C. A., & Albain, K. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912303412706 · Cited by 2,174
Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma
Krook, J. E., Moertel, C. G., Gunderson, L. L., Wieand, H. S., Collins, R. T., Beart, R. W., Kubista, T. P., Poon, M. A., Meyers, W. C., Mailliard, J. A., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103143241101 · Cited by 1,879
Kabbinavar, F., Hurwitz, H. I., Fehrenbacher, L., Meropol, N. J., Novotny, W. F., Lieberman, G., Griffing, S., & Bergsland, E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.066 · Cited by 1,716
Saltz, L. B., Meropol, N. J., Loehrer, P. J., Needle, M. N., Kopit, J., & Mayer, R. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.182 · Cited by 1,694
Self-citationColon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition Staging
O'Connell, J. B., Maggard, M. A., & Ko, C. Y. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh275 · Cited by 1,599
Benson, A. B., Schrag, D., Somerfield, M. R., Cohen, A. M., Figueredo, A. T., Flynn, P. J., Krzyzanowska, M. K., Maroun, J., McAllister, P., Van Cutsem, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.063 · Cited by 1,430
Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)
Hampel, H., Frankel, W. L., Martin, E., Arnold, M., Khanduja, K., Kuebler, P., Nakagawa, H., Sotamaa, K., Prior, T. W., Westman, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043146 · Cited by 1,408
Giacchetti, S., Perpoint, B., Zidani, R., Le Bail, N., Faggiuolo, R., Focan, C., Chollet, P., Llory, J. F., Letourneau, Y., Coudert, B., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.136 · Cited by 1,403
Rectal Cancer: The Basingstoke Experience of Total Mesorectal Excision, 1978-1997
Heald, R. J., Moran, B. J., Ryall, R. D. H., Sexton, R., & MacFarlane, J. K. (1998) · Archives of Surgery · doi:10.1001/archsurg.133.8.894 · Cited by 1,399
Tumor Microsatellite Instability and Clinical Outcome in Young Patients with Colorectal Cancer
Gryfe, R., Kim, H., Hsieh, E. T. K., Aronson, M. D., Holowaty, E. J., Bull, S. B., Redston, M., & Gallinger, S. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001133420201 · Cited by 1,388
Cunningham, D., Pyrhönen, S., James, R. D., Punt, C. J., Hickish, T. F., Heikkila, R., Johannesen, T. B., Starkhammar, H., Topham, C. A., Awad, L., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02309-5 · Cited by 1,259
Capecitabine as Adjuvant Treatment for Stage III Colon Cancer
Twelves, C., Wong, A., Nowacki, M. P., Abt, M., Burris, H., Carrato, A., Cassidy, J., Cervantes, A., Fagerberg, J., Georgoulias, V., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043116 · Cited by 1,248
Le Voyer, T. E., Sigurdson, E. R., Hanlon, A. L., Mayer, R. J., Macdonald, J. S., Catalano, P. J., & Haller, D. G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.062 · Cited by 1,149
Self-citationO'Connell, M. J., Martenson, J. A., Wieand, H. S., Krook, J. E., Macdonald, J. S., Haller, D. G., Mayer, R. J., Gunderson, L. L., & Rich, T. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408253310803 · Cited by 1,136
Self-citationHoff, P. M., Ansari, R., Batist, G., Cox, J., Kocha, W., Kuperminc, M., Maroun, J., Walde, D., Weaver, C., Harrison, E., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.8.2282 · Cited by 1,130
Van Cutsem, E., Twelves, C., Cassidy, J., Allman, D., Bajetta, E., Boyer, M., Bugat, R., Findlay, M., Frings, S., Jahn, M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.21.4097 · Cited by 1,032
Fisher, B., Wolmark, N., Rockette, H., Redmond, C., Deutsch, M., Wickerham, D. L., Fisher, E. R., Caplan, R., Jones, J., Lerner, H., et al. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.1.21 · Cited by 1,030
Gill, S., Loprinzi, C. L., Sargent, D. J., Thomé, S. D., Alberts, S. R., Haller, D. G., Benedetti, J., Francini, G., Shepherd, L. E., Francois Seitz, J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.059 · Cited by 1,021
Rougier, P., Van Cutsem, E., Bajetta, E., Niederle, N., Possinger, K., Labianca, R., Navarro, M., Morant, R., Bleiberg, H., Wils, J., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03085-2 · Cited by 992
A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly Patients
Sargent, D. J., Goldberg, R. M., Jacobson, S. D., Macdonald, J. S., Labianca, R., Haller, D. G., Shepherd, L. E., Seitz, J. F., & Francini, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010957 · Cited by 986
Kabbinavar, F. F., Schulz, J., McCleod, M., Patel, T., Hamm, J. T., Hecht, J. R., Mass, R., Perrou, B., Nelson, B., & Novotny, W. F. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.112 · Cited by 929
Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., Laurie, J. A., Tangen, C. M., Ungerleider, J. S., Emerson, W. A., Tormey, D. C., Glick, J. H., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-5-199503010-00001 · Cited by 925
de Gramont, A., Bosset, J. F., Milan, C., Rougier, P., Bouché, O., Etienne, P. L., Morvan, F., Louvet, C., Guillot, T., François, E., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.2.808 · Cited by 908
Molecular Predictors of Survival after Adjuvant Chemotherapy for Colon Cancer
Watanabe, T., Wu, T.-T., Catalano, P. J., Ueki, T., Satriano, R., Haller, D. G., Benson, A. B., & Hamilton, S. R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104193441603 · Cited by 888
Poon, M. A., O'Connell, M. J., Moertel, C. G., Wieand, H. S., Cullinan, S. A., Everson, L. K., Krook, J. E., Mailliard, J. A., Laurie, J. A., & Tschetter, L. K. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.10.1407 · Cited by 887
Systemic Therapy for Colorectal Cancer
Varghese, A. M. (2019) · DeckerMed CGSO Case-Based Reviews · doi:10.2310/cgso.16189 · Cited by 883
(2001) · The Lancet · doi:10.1016/s0140-6736(01)06409-1 · Cited by 870
Sargent, D. J., Wieand, H. S., Haller, D. G., Gray, R., Benedetti, J. K., Buyse, M., Labianca, R., Seitz, J. F., O'Callaghan, C. J., Francini, G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.6071 · Cited by 713
Laurie, J. A., Moertel, C. G., Fleming, T. R., Wieand, H. S., Leigh, J. E., Rubin, J., McCormack, G. W., Gerstner, J. B., Krook, J. E., & Malliard, J. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.10.1447 · Cited by 700
Wolmark, N., Rockette, H., Fisher, B., Wickerham, D. L., Redmond, C., Fisher, E. R., Jones, J., Mamounas, E. P., Ore, L., & Petrelli, N. J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.10.1879 · Cited by 689
Hurwitz, H. I., Fehrenbacher, L., Hainsworth, J. D., Heim, W., Berlin, J., Holmgren, E., Hambleton, J., Novotny, W. F., & Kabbinavar, F. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.017 · Cited by 688
GÉRARD, A., BUYSE, M., NORDLINGER, B., LOYGUE, J., PÈNE, F., KEMPF, P., BOSSET, J.-F., GIGNOUX, M., ARNAUD, J.-P., DESAIVE, C., et al. (1988) · Annals of Surgery · doi:10.1097/00000658-198811000-00011 · Cited by 665
Rothenberg, M. L., Oza, A. M., Bigelow, R. H., Berlin, J. D., Marshall, J. L., Ramanathan, R. K., Hart, L. L., Gupta, S., Garay, C. A., Burger, B. G., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.126 · Cited by 646
Oxaliplatin: A review of preclinical and clinical studies
Raymond, E., Chaney, S. G., Taamma, A., & Cvitkovic, E. (1998) · Annals of Oncology · doi:10.1023/a:1008213732429 · Cited by 643
The Prognosis of T3N0 Colon Cancer Is Dependent on the Number of Lymph Nodes Examined
Swanson, R. S., Compton, C. C., Stewart, A. K., & Bland, K. I. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.03.058 · Cited by 622
Rixe, O., Ortuzar, W., Alvarez, M., Parker, R., Reed, E., Paull, K., & Fojo, T. (1996) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)81490-6 · Cited by 615
O'Connell, M. J., Mailliard, J. A., Kahn, M. J., Macdonald, J. S., Haller, D. G., Mayer, R. J., & Wieand, H. S. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.246 · Cited by 585
Self-citationCellular and molecular pharmacology of oxaliplatin.
Raymond, É., Faivre, S. J., Chaney, S. G., WOYNAROWSKI, J. M., & Cvitkovic, E. (2002) · PubMed · Cited by 576
Segaert, S., & Van Cutsem, E. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi279 · Cited by 571
Impact of Number of Nodes Retrieved on Outcome in Patients With Rectal Cancer
Tepper, J. E., O’Connell, M. J., Niedzwiecki, D., Hollis, D., Compton, C., Benson, A. B., Cummings, B., Gunderson, L., Macdonald, J. S., & Mayer, R. J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.1.157 · Cited by 560
Self-citationPetrelli, N., Douglass, H. O., Herrera, L., Russell, D., Stablein, D. M., Bruckner, H. W., Mayer, R. J., Schinella, R., Green, M. D., & Muggia, F. M. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.10.1419 · Cited by 556
Self-citationFrykholm, G. J., Glimelius, B., & Påhlman, L. (1993) · Diseases of the Colon & Rectum · doi:10.1007/bf02049863 · Cited by 538
Mamounas, E., Wieand, S., Wolmark, N., Bear, H. D., Atkins, J. N., Song, K., Jones, J., & Rockette, H. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1349 · Cited by 531
Wolmark, N. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.5.388 · Cited by 530
Survival after Postoperative Combination Treatment of Rectal Cancer
(1986) · New England Journal of Medicine · doi:10.1056/nejm198611133152014 · Cited by 529
Oxaliplatin: mechanism of action and antineoplastic activity.
Raymond, É., Faivre, S. J., WOYNAROWSKI, J. M., & Chaney, S. G. (1998) · PubMed · Cited by 520
Colon Cancer Survival Is Associated With Decreasing Ratio of Metastatic to Examined Lymph Nodes
Berger, A. C., Sigurdson, E. R., LeVoyer, T., Hanlon, A., Mayer, R. J., Macdonald, J. S., Catalano, P. J., & Haller, D. G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8852 · Cited by 518
Self-citationSurvival of Blacks and Whites After a Cancer Diagnosis
Bach, P. B. (2002) · JAMA · doi:10.1001/jama.287.16.2106 · Cited by 513
Why the Epidermal Growth Factor Receptor? The Rationale for Cancer Therapy
Baselga, J. (2002) · The Oncologist · doi:10.1634/theoncologist.7-2004-2 · Cited by 510
Wolmark, N., Rockette, H., Mamounas, E., Jones, J., Wieand, S., Wickerham, D. L., Bear, H. D., Atkins, J. N., Dimitrov, N. V., Glass, A. G., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3553 · Cited by 493
Influence of Hospital Procedure Volume on Outcomes Following Surgery for Colon Cancer
Schrag, D. (2000) · JAMA · doi:10.1001/jama.284.23.3028 · Cited by 490
Age and Adjuvant Chemotherapy Use After Surgery for Stage III Colon Cancer
Schrag, D., Cramer, L. D., Bach, P. B., & Begg, C. B. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.11.850 · Cited by 481
Preoperative Carcinoembryonic Antigen Level as a Prognostic Indicator in Colorectal Cancer
Wanebo, H. J., Rao, B., Pinsky, C. M., Hoffman, R. G., Stearns, M., Schwartz, M. K., & Oettgen, H. F. (1978) · New England Journal of Medicine · doi:10.1056/nejm197808312990904 · Cited by 468
The Staging of Colorectal Cancer: 2004 and Beyond
Compton, C. C., & Greene, F. L. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.6.295 · Cited by 460
Yancik, R., & Ries, L. A. G. (2000) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70275-6 · Cited by 419
O'Connell, M. J., Laurie, J. A., Kahn, M., Fitzgibbons, R. J., Erlichman, C., Shepherd, L., Moertel, C. G., Kocha, W. I., Pazdur, R., Wieand, H. S., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.295 · Cited by 417
Mayer, A., Takimoto, M., Fritz, E., Schellander, G., Kofler, K., & Ludwig, H. (1993) · Cancer · doi:10.1002/1097-0142(19930415)71:8<2454::aid-cncr2820710805>3.0.co;2-2 · Cited by 412
Haller, D. G., Catalano, P. J., Macdonald, J. S., O'Rourke, M. A., Frontiera, M. S., Jackson, D. V., & Mayer, R. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.5686 · Cited by 391
Self-citation(2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.104 · Cited by 389
Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., Laurie, J. A., Tangen, C. M., Ungerleider, J. S., Emerson, W. A., Tormey, D. C., & Glick, J. H. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.12.2936 · Cited by 369
Reversible Posterior Leukoencephalopathy Syndrome and Bevacizumab
(2006) · New England Journal of Medicine · doi:10.1056/nejmc052954 · Cited by 365
Prewett, M. C., Hooper, A. T., Bassi, R., Ellis, L. M., Waksal, H. W., & Hicklin, D. J. (2002) · PubMed · Cited by 352
Figueredo, A., Charette, M. L., Maroun, J., Brouwers, M. C., & Zuraw, L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.087 · Cited by 348
Giantonio, B. J., Catalano, P. J., Meropol, N. J., O’Dwyer, P. J., Mitchell, E. P., Alberts, S. R., Schwartz, M. A., & Benson, A. B. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.2 · Cited by 344
Adjuvant therapy for colon and rectal cancer
Metzger, U. (1990) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(90)90136-h · Cited by 335
Lembersky, B. C., Wieand, H. S., Petrelli, N. J., O'Connell, M. J., Colangelo, L. H., Smith, R. E., Seay, T. E., Giguere, J. K., Marshall, M. E., Jacobs, A. D., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7498 · Cited by 328
Douillard, J.-Y., Hoff, P. M., Skillings, J. R., Eisenberg, P., Davidson, N., Harper, P., Vincent, M. D., Lembersky, B. C., Thompson, S., Maniero, A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.04.123 · Cited by 323
Ayanian, J. Z., Zaslavsky, A. M., Fuchs, C. S., Guadagnoli, E., Creech, C. M., Cress, R. D., O’Connor, L. C., West, D. W., Allen, M. E., Wolf, R. E., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.178 · Cited by 308
The DCC Protein and Prognosis in Colorectal Cancer
Shibata, D., Reale, M. A., Lavin, P., Silverman, M., Fearon, E. R., Steele, G., Jessup, J. M., Loda, M., & Summerhayes, I. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612053352303 · Cited by 308
Bécouarn, Y., Ychou, M., Ducreux, M., Borel, C., Bertheault-Cvitkovic, F., Seitz, J. F., Nasca, S., Nguyen, T. D., Paillot, B., Raoul, J. L., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2739 · Cited by 301
Jessup, J. M., Stewart, A., Greene, F. L., & Minsky, B. D. (2005) · JAMA · doi:10.1001/jama.294.21.2703 · Cited by 296
Carmichael, J., Popiela, T., Radstone, D., Falk, S., Borner, M., Oza, A., Skovsgaard, T., Munier, S., & Martin, C. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.129 · Cited by 268
Adjuvant or Palliative Chemotherapy for Colorectal Cancer in Patients 70 Years or Older
Popescu, R. A., Norman, A., Ross, P. J., Parikh, B., & Cunningham, D. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2412 · Cited by 264
André, T., Colin, P., Louvet, C., Gamelin, E., Bouche, O., Achille, E., Colbert, N., Boaziz, C., Piedbois, P., Tubiana-Mathieu, N., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.065 · Cited by 262
EGF, TGF-a, and EGF-R in Human Colorectal Adenocarcinoma
Messa, C., Russo, F., Gabriella Caruso, M., & Di Leo, A. (1998) · Acta Oncologica · doi:10.1080/028418698429595 · Cited by 251
Tepper, J. E., O'Connell, M. J., Petroni, G. R., Hollis, D., Cooke, E., Benson, A. B., Cummings, B., Gunderson, L. L., Macdonald, J. S., & Martenson, J. A. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.2030 · Cited by 250
Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer
Francini, G., Petrioli, R., Lorenzini, L., Mancini, S., Armenio, S., Tanzini, G., Marsili, S., Aquino, A., Marzocca, G., Civitelli, S., et al. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90748-x · Cited by 241
Porębska, I., Harłozińska, A., & Bojarowski, T. (2000) · Tumor Biology · doi:10.1159/000030116 · Cited by 234
Greene, F. L., Stewart, A. K., & Norton, H. J. (2002) · Annals of Surgery · doi:10.1097/00000658-200210000-00003 · Cited by 230
Díaz-Rubio, E., Sastre, J., Zaniboni, A., Labianca, R., Cortés-Funes, H., de Braud, F., Boni, C., Benavides, M., Dallavalle, G., & Homerin, M. (1998) · Annals of Oncology · doi:10.1023/a:1008200825886 · Cited by 228
Sundararajan, V., Mitra, N., Jacobson, J. S., Grann, V. R., Heitjan, D. F., & Neugut, A. I. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-5-200203050-00007 · Cited by 225
Determinants of Black/White Differences in Colon Cancer Survival
Mayberry, R. M., Coates, R. J., Hill, H. A., Click, L. A., Chen, V. W., Austin, D. F., Redmond, C. K., Fenoglio-Preiser, C. M., Hunter, C. P., Haynes, M. A., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.22.1686 · Cited by 222
Relation of Hospital Volume to Colostomy Rates and Survival for Patients With Rectal Cancer
Hodgson, D. C., Zhang, W., Zaslavsky, A. M., Fuchs, C. S., Wright, W. E., & Ayanian, J. Z. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.10.708 · Cited by 217
Stocchi, L., Nelson, H., Sargent, D. J., O’Connell, M. J., Tepper, J. E., Krook, J. E., Beart, R., & the North Central Cancer Treatment Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.18.3895 · Cited by 212
Vascular and neural invasion in colorectal carcinoma.Incidence and prognostic significance
Krasna, M. J., Flancbaum, L., Cody, R. P., Shneibaum, S., & Ari, G. B. (1988) · Cancer · doi:10.1002/1097-0142(19880301)61:5<1018::aid-cncr2820610527>3.0.co;2-h · Cited by 212
Wolmark, N., Rockette, H., Wickerham, D. L., Fisher, B., Redmond, C., Fisher, E. R., Potvin, M., Davies, R. J., Jones, J., & Robidoux, A. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.9.1466 · Cited by 211
Popat, S., & Houlston, R. S. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.039 · Cited by 187
Explaining Black–White Differences in Receipt of Recommended Colon Cancer Treatment
Baldwin, L.-M., Dobie, S. A., Billingsley, K., Cai, Y., Wright, G. E., Dominitz, J. A., Barlow, W., Warren, J. L., & Taplin, S. H. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji241 · Cited by 187
Chau, I., Norman, A. R., Cunningham, D., Tait, D., Ross, P. J., Iveson, T., Hill, M., Hickish, T., Lofts, F., Jodrell, D., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi116 · Cited by 186
Wolmark, N., Wieand, S., Kuebler, J. P., Colangelo, L., & Smith, R. E. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.lba3500 · Cited by 176
Racial differences in colorectal cancer mortality
Marcella, S., & Miller, J. E. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00316-4 · Cited by 175
Ward, S., Kaltenthaler, E., Cowan, J., & Brewer, N. (2003) · Health Technology Assessment · doi:10.3310/hta7320 · Cited by 162
Meyerhardt, J. A., Tepper, J. E., Niedzwiecki, D., Hollis, D. R., Schrag, D., Ayanian, J. Z., O’Connell, M. J., Weeks, J. C., Mayer, R. J., Willett, C. G., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.172 · Cited by 155
Self-citationPolite, B. N., Dignam, J. J., & Olopade, O. I. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.4775 · Cited by 150
McCollum, A. D. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.15.1160 · Cited by 146
Rothenberg, M. L., LaFleur, B., Levy, D. E., Washington, M. K., Morgan-Meadows, S., Ramanathan, R. K., Berlin, J. D., Benson, A. B., & Coffey, R. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.0536 · Cited by 145
Adjuvant therapy of colon cancer
Macdonald, J. S. (1999) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.49.4.202 · Cited by 139
FIELDING, L. P., Hittinger, R., Grace, R., & Fry, J. S. (1992) · The Lancet · doi:10.1016/0140-6736(92)91708-g · Cited by 136
Cutsem, E. V., Labianca, R., Hossfeld, D., Bodoky, G., Roth, A. D., Aranda, E., Nordlinger, B., Assadourian, S., Wang, K., & Cunningham, D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.lba8 · Cited by 130
Portal Vein Chemotherapy for Colorectal Cancer: a Meta-analysis of 4000 Patients in 10 Studies
Liver Infusion Meta-analysis Group (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.7.497 · Cited by 127
Gray, R. G., Barnwell, J., Hills, R. K., McConkey, C., Williams, N., & Kerr, R. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.90140.3501 · Cited by 126
Hahn, R. G., Moertel, C. G., Schutt, A. J., & Bruckner, H. W. (1975) · Cancer · Cited by 116
Adjuvant chemotherapy in the surgical treatment of large bowel cancer
Higgins, G. A., Humphrey, E., Juler, G. L., LeVeen, H. H., McCaughan, J. J., & Keehn, R. J. (1976) · Cancer · Cited by 113
Beart, R. W. (1990) · Archives of Surgery · doi:10.1001/archsurg.1990.01410190095015 · Cited by 108
Saltz, L. B., Niedzwiecki, D., Hollis, D. R., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.90140.3500 · Cited by 104
CPT-11 in gastrointestinal cancer
Bleiberg, H. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00423-7 · Cited by 102
New Tumor-Node-Metastasis Staging Strategy for Node-Positive (stage III) Rectal Cancer: An Analysis
Greene, F. L., Stewart, A. K., & Norton, H. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.015 · Cited by 95
Oral fluoropyrimidines in the treatment of colorectal cancer
Meropol, N. J. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00226-3 · Cited by 91
Polite, B. N., Dignam, J. J., & Olopade, O. I. (2005) · Medical Clinics of North America · doi:10.1016/j.mcna.2005.03.001 · Cited by 89
The NCCN Clinical Practice Guidelines in Oncology: A Primer for Users
Winn, R. J., & McClure, J. S. (2003) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2003.0003 · Cited by 85
Safety and efficacy of panitumumab monotherapy in patients with metastatic colorectal cancer (mCRC)
Malik, I. A., Hecht, J. R., Patnaik, A., Venook, A. P., Berlin, J. D., Croghan, G. A., Navale, L., MacDonald, M., Jerian, S., & Meropol, N. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.3520 · Cited by 84
Epidermal growth factor receptor‐targeted treatment for advanced colorectal carcinoma
Venook, A. P. (2005) · Cancer · doi:10.1002/cncr.21123 · Cited by 80
Epidermal growth factor receptor expression and measurement in solid tumors
Spaulding, D., & Spaulding, B. O. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70090-0 · Cited by 61
Sobrero, A. F., Guglielmi, A., Grossi, F., Puglisi, F., & Aschele, C. (2000) · PubMed · Cited by 57
Dignam, J. J., Ye, Y., Colangelo, L. H., Smith, R. E., Mamounas, E. P., Wieand, H. S., & Wolmark, N. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.004 · Cited by 49
Grossi, C. E., Wolff, W. I., Nealon, T. F., Pasternack, B. S., Ginzburg, L., & Rousselot, L. M. (1977) · PubMed · Cited by 31
Adjuvant Therapy of Colorectal Cancer: Why We Still Don't Know
Buyse, M. (1988) · JAMA · doi:10.1001/jama.1988.03720240033031 · Cited by 18
Adjuvant Treatment of Colorectal Cancer in the Elderly.
Aschele, C., Guglielmi, A., Tixi, L., Bolli, E., Mori, A., Lionetto, R., Rosso, R., & Sobrero, A. F. (1995) · PubMed · Cited by 14
Local Excision of Rectal Cancer Oncologic Results
Greenberg, J. A., & Bleday, R. (2005) · Seminars in Colon and Rectal Surgery · doi:10.1053/j.scrs.2005.04.002 · Cited by 7
Cited by
Bertagnolli, M. M., Niedzwiecki, D., Compton, C. C., Hahn, H. P., Hall, M., Damas, B., Jewell, S. D., Mayer, R. J., Goldberg, R. M., Saltz, L. B., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.2071 · Cited by 364
Self-citationPostoperative adjuvant chemotherapy in rectal cancer operated for cure.
Petersen, S. H., Harling, H., Kirkeby, L. T., Wille-Jørgensen, P., & Mocellin, S. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004078.pub2 · Cited by 326
Brenner, H., Bouvier, A. M., Foschi, R., Hackl, M., Larsen, I. K., Lemmens, V., Mangone, L., Francisci, S., & The EUROCARE Working Group (2012) · International Journal of Cancer · doi:10.1002/ijc.26192 · Cited by 258
Wolpin, B. M., Meyerhardt, J. A., Chan, A. T., Ng, K., Chan, J. A., Wu, K., Pollak, M. N., Giovannucci, E. L., & Fuchs, C. S. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.9945 · Cited by 231
Colon and rectal cancer: An emergent public health problem
Pinheiro, M., Moreira, D. N., & Ghidini, M. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i7.644 · Cited by 80
“Thus, the preoperative measurement of CEA is extremely relevant, as its high levels are associated with a higher risk of cancer recurrence[31].”
Metadata
- Authors
- Wolpin, B. M., Meyerhardt, J. A., Mamon, H. J., & Mayer, R. J.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2007-05-01
- Volume
- 57
- Issue
- 3
- Pages
- 168-185
- ISSN
- 0007-9235 (ISSN-L)
- OpenAlex
- W2001601360
- Cited by
- 306
- References
- 134
- FWCI
- 15.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.